Tickers — W

57 tickers
Ranks this page's recent reports by score.
WisdomTree, Inc.
WT·Financials
B ★★★Hold
Current$20.37
Target$24.30
Return+19.3%
Nov 2, 2026

WisdomTree combines strong organic AUM growth, scalable ETF economics and expanding alternative investment capabilities, but acquisition-related leverage and elevated historical valuation multiples limit the immediate margin of safety.

Score
68
Willis Towers Watson Public Limited Company
WTW·Financials
S ★★★★★Strong Buy
Current$325.71
Target$366.56
Return+12.5%
Nov 2, 2026

Willis Towers Watson combines a durable advisory and insurance brokerage franchise with attractive cash generation and margin expansion opportunities, although transformation costs and competitive talent pressure remain key risks.

Score
88
Cactus, Inc.
WHD·Energy
B ★★★Hold
Current$65.70
Target$67.45
Return+2.7%
Nov 2, 2026

Cactus combines high-margin engineered oilfield equipment, expanding international opportunities, and a strong balance sheet, but energy-cycle exposure and demanding cash-flow growth expectations constrain near-term upside.

Score
72
Wingstop Inc.
WING·Consumer Discretionary
B ★★★Hold
Current$149.73
Target$156.80
Return+4.7%
Nov 2, 2026

Wingstop's asset-light franchise model and global unit expansion support long-term earnings growth, but persistent domestic same-store sales declines and elevated leverage threaten the pace of recovery.

Score
67
Welltower Inc.
WELL·Real Estate
C ★★Sell
Current$234.60
Nov 2, 2026

Welltower benefits from structural senior housing demand, improving occupancy, and strong property-level earnings growth, but its expensive valuation and acquisition-related dilution limit prospective shareholder returns.

Score
63
Weyerhaeuser Company
WY·Real Estate
B ★★★Hold
Current$20.35
Target$24.30
Return+19.4%
Nov 1, 2026

Weyerhaeuser offers asset-backed upside from timberland ownership and a potential housing recovery, but weak current returns, elevated leverage, and insufficient recurring cash flow constrain the investment case.

Score
70
West Pharmaceutical Services, Inc.
WST·Healthcare
B ★★★Hold
Current$412.62
Target$388.74
Return-5.8%
Nov 1, 2026

West Pharmaceutical Services benefits from entrenched pharmaceutical containment relationships and rising demand for premium injectable components, but its elevated valuation requires sustained growth and stronger cash conversion.

Score
69
Werner Enterprises, Inc.
WERN·Industrials
C ★★Sell
Current$27.71
Nov 1, 2026

Werner's Dedicated trucking expansion and improving fleet productivity offer cyclical recovery potential, but weak operating margins, acquisition leverage, and limited free cash flow constrain shareholder returns.

Score
59
WPP plc
WPP·Communication Services
D ★Strong Sell
Current$27.18
Nov 1, 2026

WPP could recover through integrated advertising services and Elevate28 cost savings, but persistent client losses, weak organic growth and substantial restructuring demands undermine confidence in durable earnings recovery.

Score
54
Westlake Corporation
WLK·Materials
C ★★Sell
Current$68.28
Nov 1, 2026

Westlake offers cyclical recovery potential through integrated chemicals and differentiated building products, but persistent oversupply, weak capital returns, and negative free cash flow threaten the durability of its earnings rebound.

Score
60
WESCO International, Inc.
WCC·Industrials
B ★★★Hold
Current$343.11
Target$378.00
Return+10.2%
Nov 1, 2026

WESCO combines expanding data center infrastructure demand with improving distribution margins and a record backlog, but its elevated historical valuation and working-capital intensity limit the margin of safety.

Score
68
WEC Energy Group, Inc.
WEC·Utilities
B ★★★Hold
Current$116.07
Target$118.75
Return+2.3%
Nov 1, 2026

WEC Energy offers durable regulated utility earnings, growing electricity demand and reliable dividends, but heavy capital requirements, leverage and a demanding valuation constrain shareholder upside.

Score
67